Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lupus Erythematosus, Systemic × Exercise × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 203 Breast Neoplasms 110 Neoplasms 89 Prostatic Neoplasms 32 Fatigue 27 Obesity 22 Colorectal Neoplasms 20 Lung Neoplasms 15 Colonic Neoplasms 15 Polycystic Ovary Syndrome 13 Ovarian Neoplasms 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Head and Neck Neoplasms 10 Rectal Neoplasms 9 Lymphoma 9 Lymphedema 9 Hematologic Neoplasms 9 Multiple Myeloma 8 Brain Neoplasms 8 Weight Loss 7 Pancreatic Neoplasms 7 Insulin Resistance 7 Cardiotoxicity 7 Carcinoma, Non-Small-Cell Lung 7 Leukemia 6 Cognitive Dysfunction 6 Sarcopenia 5 Peripheral Nervous System Diseases 5 Overweight 5 Lymphoma, Follicular 5

Interventions

Nivolumab 2 sotrovimab 1 gusacitinib 1 ciclesonide 1 Standard of Care 1 Specimen Handling 1 Procalcitonin 1 Practice Guidelines as Topic 1 Niclosamide 1 Methods 1 Interviews as Topic 1 Immune Checkpoint Inhibitors 1 High-Intensity Interval Training 1 Exercise 1 Educational Status 1 Early Intervention, Educational 1 Cholecalciferol 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05478018 2025-09-09

LUPEX

Rigshospitalet, Denmark

Phase NA Completed

Lupus Erythematosus, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡